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Summary 
The T  cell receptor for antigen (TClL) is a multisubunit complex that consists  of at least seven 
polypeptides: the clonotypic, disulfide-linked oe/[3 heterodimer that is noncovalently associated 
with the invariant polypeptides of the CD3 complex (CD3-~/, -8, -e) and ~, a disulfide-linked 
homodimer. We achieved the complete assembly of the human TCR in an in vitro transcrip- 
tion/translation system supplemented with dog pancreas microsomes by simultaneous transla- 
tion of the messenger lLNAs encoding the TCR-cx, -[3 and CD3-~/,  -8, -e, and -~ subunits. 
CD3-e, one of the subunits that initiates the assembly of the TCR in living cells, forms ntis- 
folded, disulfide-linked homooligomers when translated alone. However, co-translation of one 
of its first  binding partners in the course of assembly, CD3-~/ or -8, led to the expression of 
mainly monomeric and correctly folded e subunits, the only form we could detect as part of a 
properly assembled TCR complex. In the absence of these subunits, the ER-resident chaper- 
one calnexin interacted with oligomeric, i.e. misfolded, structures of CD3-e in a glycan-inde- 
pendent manner. A glycan-dependent interaction between CD3-e and calnexin was mediated 
by CD3-3, and concerned only monomeric CD3-e complexed with CD3-~/, but was dispens- 
able for proper folding of CD3-e. We suggest that in addition to its signaling function, CD3-e 
serves as a monitor for proper subunit assembly of the TClL. 
M 
OSt  T  lymphocytes express  on  their plasma  mem- 
brane  the  TClL-CD3  complex.  This  multisubunit 
receptor has  served as  a paradigm  for the  analysis  of the 
biogenesis of multimembrane proteins, and shown how, in 
the absence of a properly assembled complex, the remain- 
ing subunits  are purged  from the  endoplasmic  reticulum 
(ElL)' (1). 
At the cell surface, the clonotypic TC1L-ci and -[3 sub- 
units appear as a disulfide-linked heterodimer that consti- 
tutes the true ligand binding unit and determines the speci- 
ficity of the receptor. To transduce extracellular signals into 
the  cytoplasm,  the  TCtk  associates  noncovalently with  a 
number of accessory polypeptides, jointly referred to as the 
CD3 complex. This complex consists  of the evolutionarily 
related CD3-'y, -8, and -e subunits, all of which belong to 
the Ig gene family (2-4), and a disulfide-linked homodimer 
of the TClL-~ subunit. The ~ chain, a member of the gene 
family that also includes the y  chain of the high affinity IgE 
receptor, lies largely on the cytoplasmic side of the plasma 
membrane and has  an  extracellular domain of only nine 
residues (5). Although the occurrence of~/e, Be, 8~ot, ",/e[3, 
m~ 
1Abbreviations used in  this paper: 7-O-dec, N-7-oxadecyl-dNM; DTT, 
dithiothreitol; EndoH, endoglycosidase  H; ER, endoplasmic reticulum; 
GSSG, oxidized glutathion; HA,  hemagglutinin; mRNA, messenger 
RNA; VSV-G protein,  vesicular  stomatitis virus G protein. 
oL[3~/Se2, and o~[3~/8e2~  2 structures has been reported in vivo 
(6,  7),  the exact stoichiometry of a completely assembled 
TClL-CD3 complex remains to be determined accurately (8). 
Besides fulfilling signaling functions,  the  CD3  subunits 
and the ~ chain are also required for cell surface expression 
of the  TClL-cx/[3 heterodimer (9,  10).  The efficiency of 
TCR  assembly in the ER  determines receptor density at 
the cell surface of T  cells; single subunits that fail to join a 
complex are retained in the ElL and subsequently degraded 
(11),  whereas partial  complexes are targeted to lysosomal 
compartments for destruction (10). 
The molecular determinants underlying the subunit-spe- 
cific interactions that promote assembly and the degrada- 
tion of  single TCR-CD3 subunits in the ElL have been the 
subject of intensive research, but are still not fully under- 
stood. Experimental evidence supports an assembly model 
based on salt bridges formed in the lipid bilayer between 
charged residues within the transmembrane of the individ- 
ual TClL subunits (12). The presence of these charged resi- 
dues in the transmembrane domains of single  TClL-ot, -[3, 
and CD3-8 subunits has been shown to play a key role in 
rapid ElL degradation (13).  In addition, the role of extra- 
cellular domains in the assembly of the TClL subunits has 
been well documented in several studies (14,  15). Further- 
more, the { homodimer seems to monitor the quaternary 
structure of the partial TClL-CD3 complex to ensure that 
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surface.  It is seen  in  association  only with  completely  as- 
sembled receptor complexes and,  in the  absence of {2 ho- 
modimers, surface expression of TCR  is compromised (10). 
The {2 homodimer may be associated with the TCR  com- 
plex  only peripherally,  as  it  can  apparently be  exchanged 
for { subunits that reside at the cell surface (16). 
The molecular chaperone calnexin (IP90, p88) is also in- 
volved in  the  assembly of TCR.  Originally  discovered  in 
association with partially assembled TCR  complexes devoid 
of ~ subunits  and  in  association  with  MHC  class I  mole- 
cules (17,  18), calnexin and its close relative calreticulin fa- 
cilitate protein folding in the ER  (19).  Although  calnexin 
can act exclusively as a lectin, binding to monoglucosylated 
trimming intermediates of N-linked glycans attached to the 
target polypeptide  (20),  the initially glycan-dependent  cal- 
nexin-MHC  class I interaction was maintained after the re- 
moval of the  N-linked glycans  (21).  Furthermore,  glycan- 
independent  binding  between  calnexin  and  aggregates  of 
the  vesicular  stomatitis  virus  G  protein  (VSV-G  protein) 
has been reported (22). Because calnexin associates with all 
TCR  subunits  except TCR-{  (17,  18,  23,  24),  it has been 
suggested  that  it  promotes  the  assembly of ot[3yBe2  com- 
plexes. The half-life of newly synthesized TCR-ot proteins 
that fail to join a TCR  complex and become a target of ER 
degradation  is significantly prolonged  due  to their interac- 
tion with calnexin  (23). However, the extent to which cal- 
nexin is involved in the folding of the individual TCR  sub- 
units  and  the  assembly of the  TCR-CD3  complex  is not 
known. 
The role of the CD3 subunits in TCR  assembly has been 
explored  mostly  in  transfection-based  expression  systems. 
The requirement  for the simultaneous presence of all CD3 
subunits  for proper complex formation has been  convinc- 
ingly demonstrated.  However,  the  contribution  of the  in- 
dividual  TCR  subunits  to  folding,  assembly,  and  quality 
control, such as the monitoring of proper quaternary struc- 
ture, has received far less attention. 
We have studied the assembly of the human TCR--CD3 
complex  with  a  particular  focus  on  early  events  of this 
process,  using  a  cell-free  translation  system supplemented 
with dog pancreas microsomes.  Optimization  of the trans- 
lation conditions allow the simultaneous translation of nine 
different messenger RNAs  (mRNAs) with high efficiency. 
If proper redox conditions  are imposed on the ER-derived 
microsomes, we observe correct folding of translated poly- 
peptides, which are assembled in a subunit-specific  manner 
into  TCR-CD3  complexes  indistinguishable  from  those 
reported for living cells. We have used this in vitro system 
to monitor the folding of CD3-~ in an early stage of TCR 
assembly, a process influenced dramatically by the presence 
of related CD3 subunits.  Translation of CD3-e alone gives 
rise mainly to misfolded,  disulfide-linked  homooligomeric 
structures,  the  formation  of which  was  substantially  sup- 
pressed when CD3-~/or -8 were translated in the same re- 
action. The molecular chaperone calnexin was found to bind 
oligomeric forms of CD3-e in a glycan-independent manner. 
When  CD3-%  which  carries  two  N-linked  glycans,  was 
translated simultaneously, monomeric CD3-e interacted with 
calnexin exclusively in a glycan-dependent manner. We pro- 
pose a role for CD3-~ in sensing the quarternary structure 
of the TCR-CD3  complex. 
Materials and Methods 
DNA  Constructs.  The cDNAs encoding the HA1.7 TCR-c~ 
and -[3 chains were provided by Dr. M.J. Owen (imperial Cancer 
Research  Fund,  London,  UK;  reference 25).  We  obtained  the 
cDNAs  encoding CD3-'y, -B and -{  (2-4)  and TCR-~  (5,  26) 
from Dr.  C.  Terhorst  (Beth  Israel  Hospital, Boston,  MA).  The 
cDNAs encoding HLA-DRI-o~ (27)  and -[3 chains  (28)  were a 
gift from Dr. Trowsdale (Human Immunogenetics Group, Impe- 
rial Cancer Research Fund,  London,  UK). The sequences  which 
encode the cleavable signal peptide of the TCR-e~, -[3, CD3-% -8, 
-e, TCR-~, and HLA-DRI-f3 were exchanged for the signal pep- 
tide encoding sequence of the mouse class I heavy chain H2-K  b. 
The CD4 encoding cDNA (29) was cloned into pSP64 (Promega 
Corp., Madison, WI) under the control of the SP6 promotor. All 
other cDNAs were cloned into pSP72 (Promega Corp.) under the 
control of the T7 promotor. 
Antibodies and Reagents.  The  following  mouse  mAbs  were 
used in this study: Tfi36 (30) recognizes properly conformed HLA- 
DR1 heterodimers, OKT4 (31, 32), which is reactive against prop- 
erly conformed human  CD4  and  OKT3  (31),  recognizes  CD3 
(both obtained from American Type Culture Collection, Rock- 
ville, MD). JOVI. 1 and JOVI.3 were raised against human TCR-[3 
(V[33C[31; 33) and TIA-2 recognizes preferentially human TCR-~ 
homodimers (34; gift from Dr. P. Anderson, Dana-Farber Cancer 
Institute, Boston, MA). 
The  following polyclonal  rabbit antisera were  used:  antisera 
raised against the cytoplasmic tails of CD3-~/, -B and -e were pro- 
vided by Dr. J. Coligan (National Institutes of Health, Bethesda, 
MD)  and the antisera raised against the human TCR-ot and -[3 
chain (35) were a gift from Dr. O. Acuto (Institut Pasteur, Paris, 
France). The rabbit polyclonal antiserum against the COOH ter- 
minus of canine calnexin was purchased  from StressGen Biotech- 
nologies Corp. (Victoria, Canada). 
The  HLA-DRl-presentable  peptide  from  influenza  virus 
HA306-318  (36) has been synthesized in the lab by 9-fluorenyl- 
methoxycarbonyl  chemistry.  Cycloheximide  and  iodoacetamide 
were purchased from Sigma Chemical Co. (St. Louis, MO). 
Gel Electrophoresis.  SDS-glycine  electrophoresis  (SDS-PAGE) 
was performed as described (37).  SDS-glycine gels were fluoro- 
graphed  using  DMSO-2,5-diphenyl  oxazole  (Sigma  Chemical 
Co.) and exposed to XAR-5 films (Kodak, Rochester, NY). 
In  Vitro Transcription and In Vitro Translation.  In  vitro  tran- 
scriptions  were  performed  using  T7  or  SP6  RNA  polymerase 
(Promega Corp.). RNA was equipped with a GS'ppp  5' N-cap struc- 
ture either co- or posttranscriptionally according to the vendor's 
instructions  (Promega Corp.). RNA was stored in water at -80°C. 
The optimal amount of RNA for translation was determined em- 
pitically for each stock of RNA prepared. Before its use in trans- 
lations,  the RNA was heated (80°C)  for 2 min and subsequently 
chilled on ice. 
In vitro translations  were previously described (38).  Reaction 
times were  indicated  in  the  results  section.  Reticulocyte  lysate 
without  supplemented  dithiothreitol  (DTT)  (Flexi TM) was pur- 
chased from Promega. Microsomes were prepared from dog pan- 
creas as described (39). 
Immunoprecipitation and Endoglycosidase H  Digestion.  After trans- 
lation,  microsomes were pelleted by centrifugation (5415C  cen- 
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sequence leads to improved translation efficiency. In vitro transcripts of 
indicated TCR subunits, equipped either with the endogenous 5' un- 
translated region and the sequence or with the corresponding  sequence of 
the murine MHC class I molecule K  b (end. K  ~) were translated in the 
presence ofmicrosornes for 1 h at 30°C. Total microsome-associated  ma- 
terial was analyzed by SDS-PAGE (12.5%) performed under reducing 
conditions. 
trifuge;  Eppendorf North America,  Inc.,  Madison,  WI;  14,000 
rpm, 10 min) and subsequently lysed for 30 rain on ice in 1 ml NP- 
40 lysis buffer (0.5% NP-40,  50 mM Tris-HC1, pH 7.4,  5 mM 
MgC12) or digitonin (Wako, Kyoto, Japan)  lysis mix (1% digito- 
nin, 150 mM NaC1, 50 mM Tris-HC1, pH 7.4) containing 1 mM 
phenylmethylsulfonyl fluoride  (Sigma  Chemical  Co.).  Insoluble 
debris was removed by centrifugation  (14,000 rpm, 10 min). Super- 
natants were precleared twice with either normal rabbit or mouse 
serum and formalin fixed Staphylococcus aureus and then immuno- 
precipitated with the indicated antibodies  as described elsewhere 
(38). Digestions  with endoglycosidase H  (EndoH)f (New England 
Biolabs,  Beverly,  MA)  were  performed  on  immune  complexes 
bound to S. aureus according to the vendor's instruction. 
Results 
Exchange of the  5' Noncoding and  Signal Peptide-encoding 
Sequence Leads to Improved Translation Efficiency.  The  transla- 
tional performance of  the mRNAs encoding the TCR  sub- 
units was optimized to ensure the likelihood of subsequent 
assembly of subunits  translated  simultaneously.  We  substi- 
tuted the 5' untranslated sequence as well as the signal pep- 
tide encoding sequence of all cDNAs with the correspond- 
ing sequence of the murine MHC  class I molecule K b, the 
in  vitro  transcript  of which  had  proven  to  be  translated 
with  high  ef~ciency (40).  A  comparison of the  translation 
products of both sets ofmRNAs  bearing either the endog- 
enous or the K b signal sequence shows that in all cases this 
substitution  led to an  enhanced translation  efficiency (Fig. 
1). This holds true as well for the translation of CD3-8, the 
nonmodified in vitro  transcript  that failed to be  translated 
(data not shown).  Since sequence  substitution  as described 
above did not affect the mobility of the translation products 
in  SDS-PAGE, we performed  all  subsequent  experiments 
with modified mRNAs. 
Proper N-linked  Glycosylation of TCR  Subunits In  Vitro. 
In living cells,  TCR-~,  -[3,  CD3-',/and 8, but not CD3-¢ 
and  the  ~ subunit  are  co-translationally  N-glycosylated in 
the lumen  of the ER.  To confirm proper glycosylation in 
vitro, we translated the mRNAs of all TCR  subunits indi- 
395  Huppa and Ploegh 
Figure 2.  Proper N glycosylation  of in vitro translated TCR subunits. 
In vitro transcripts of the indicated TCR subunits were translated for 1 h 
at  30°C. Immuuoprecipitates obtained with  the appropriate antibodies 
were either mock digested or digested with EndoH, and subsequently an- 
alyzed by SDS-PAGE (12.5%) performed under reducing conditions. The 
lower band in the anti--CD3-e immunoprecipitates may constitute a deg- 
radation product of CD3-e. 
vidually in the presence ofmicrosomes, followed by recov- 
ery of the translation products by immunoprecipitation us- 
ing  the  appropriate  antibodies.  Immunoprecipitates  were 
digested with EndoH or mock digested to remove N-linked 
glycans (Fig. 2).  The number of glycans attached could be 
estimated for in vitro translated TCR-et  (four glycans), -13, 
CD3-~/ and -8  (two glycans), and CD3-~  and -~  (no gly- 
cans), all in agreement with in vivo data (2-5, 25). 
Proper Formation of lntra- and Intermolecular Disulfide Bridges 
Depends on Redox Conditions and Is Essential  for Correct Fold- 
ing.  The formation of disulfide  bridges  occurs in the lu- 
men  of the  ER  both  co-  and  posttranslationally,  and  re- 
quires an oxidizing environment. Disulfide bonds constrain 
the  tertiary  structure  and help  maintain  the  conformation 
ofa polypeptide chain (41-43).  In this study, we used con- 
formation-specific mAbs to monitor disulfide bond-depen- 
dent folding. TCR-13 and CD4 translated in the presence of 
the reducing agent DTT  do not acquire  their  native  con- 
formation, demonstrated by their failure to bind to JOVI. 1, 
JOVI.3  (anti-TCRI3  mAbs)  and OKT4  (anti-CD4  mAb), 
respectively. However, the epitopes recognized by all three 
antibodies were recovered upon inclusion of oxidized glu- 
tathion (GSSG)  (Fig. 3 A) in a dose-dependent manner. 
Similarly, disulfide bond-mediated homodimerization of 
the ~ subunit is dependent  on proper redox conditions.  In 
the presence of 4  mM DTT,  ~ homodimers could not be 
detected  with  TIA-2  (anti-~  mAb,  reacting  preferentially 
with  dimeric  ~)  but  were  recovered  upon  addition  of 
GSSG  (Fig.  3  B).  We  conclude that the proper formation 
of intra-  and  intermolecular  disulfide  bonds  in  vitro  re- 
quires an oxidizing environment and is essential for correct 
folding. 
Assembly of the Human  TCR Complex  Translated In  Vitro 
Is a Subunit-specific Process and Requires the Simultaneous Trans- 
lation of All Polypeptides Involved.  Because the complexity of Figure 3.  Redox conditions determine the proper formation of intra- 
and intermolecular disulfide  bonds in vitro.  (A) Formation of intrachain 
disulfide bridges and proper folding of TCR-13 and CD4 is dependent on 
an oxidizing environment; TCR-[3 and CD4 were translated  for 1 h  at 
30°C in the presence of DTT and GSSG at the indicated concentrations. 
Immunoprecipitations were performed with the indicated conformation- 
specific antibodies after lysis of the rnicrosomes in NP-40 lysis buffer in 
the presence of 50 mM iodoacetamide. Total microsome-associated  ma- 
terial  as  well  as  immunoprecipitates  were  analyzed  by  SDS-PAGE 
(12.5%), performed under nonreducing conditions. (/3) The formation of 
disulfide-linked ~ dimers occurs  under proper redox conditions: TCR-~ 
was translated for 1 h at 30°C in the presence of DTT and GSSG at indi- 
cated concentrations. Lysates were prepared in NP-40 lysis buffer in the 
presence of 50 mM iodoacetamide and subjected to immunoprecipitation 
using the mAb TIA-2. The ~ homodimer migrates in SDS-PAGE (12.5%) 
performed under nonreducing as a complex with a molecular weight of 
30 kD  but is converted to monomeric TCR-~ if analyzed  by reducing 
SDS-PAGE. Total microsome-associated material was analyzed by reduc- 
ing SDS-PAGE and serves as a control for the quantity of TCR-~  ex- 
pressed. 
polypeptides  resulting  from  in  vitro  translation  is  limited 
and their specific radioactivity is high, specificity ofimmu- 
noprecipitation  must  be  rigorously  established.  All  TCR 
subunits were  therefore  translated separately  (Fig.  4  A,  left), 
and  the microsomes  lysed  in  digitonin lysis buffer.  Lysates 
of the  different  translations  were  pooled  and  subjected  to 
Figure  4.  Assembly  of the TCR-CD3  complex is a subunit-specific 
process  and does not occur after lysis. (A) Test for antibody specificity 
confirms that in vitro assembly of the TCR-CD3 complex does not oc- 
cur after lysis. (Left) Indicated mRNAs were translated individually for 1 h 
at 30°C,  and an aliquot of the total microsome-associated material of each 
reaction was directly analyzed by reducing SDS-PAGE (12.5%). (Middle) 
Microsomes of individual translation reactions (left) were lysed in digito- 
nin lysis buffer. Lysates were pooled to generate a mixture of labeled sub- 
units, and subjected to immunoprecipitation using the antibodies indi- 
cated.  (Right) Digitonin lysates of the individual translation reactions  (left) 
were subjected to immunoprecipitation performed with a mixture of all 
antibodies used (middle),  but lacking the indicated antibodies specific for the 
translated subunit. The lack of recovery of labeled subunits in this experi- 
ment indicates that none of the antibodies used react with the inappropri- 
ate subunits.  (B) Subunit specific assembly of the TCR-CD3 complex in 
vitro. Nine mRNAs encoding all subunits of the TCR-CD3 complex as 
well as  CD4  and HLA-DRoc  and HLA-DR[3  were translated simulta- 
neously. Microsomes  were either analyzed directly by SDS-PAGE (12.5%) 
or  subjected  to  immunoprecipitation using  OKT4  (anti-CD4),  Tii36 
(anti-HLA-DR), JOVI.1  (anti-TCR-[3) or OKT3  (anti-CD3). Precipi- 
tates obtained with OKT4 and T/i36 were analyzed by SDS-PAGE (12.5%) 
performed under reducing conditions, b, boiled; nb, non-boiled. SDS-sta- 
ble DR dimers are indicated as DRec[3. Immunoprecipitates  obtained with 
JOVI.1  and OKT3  were analyzed by SDS-PAGE  (12.5%)  performed 
under reducing and nonreducing conditions. To  resolve  TCR-~  from 
TCR-[3, these samples were also first digested with EndoH and then sep- 
arated by SDS-PAGE  12.5%). 
immunoprecipitatmon using the antibodies as indicated (Fig. 
4 A), or lysates of the individual translations were immuno- 
precipitated  with  a  mixture  of antibodies lacking only the 
antibody  specific  for  the  translated polypeptide  (Fig.  4  A, 
middle). 
All of the antibodies used precipitated exclusively the ap- 
propriate  chain  from  a  polypeptide  mix  (Fig.  4  A,  middle) 
but failed to  recover inappropriate  polypeptides  (Fig.  4  A, 
396  In Vitro Assembly of the TCR-CD3  Complex right).  This  result  also  demonstrates  that  assembly of the 
TCR  does not  occur artefactually after lysis,  but  requires 
the presence of all subunits in a shared membrane compart- 
ment (see below). 
To  examine  subunit-specific  assembly of the  TCIk  in 
vitro, we translated simultaneously all chains of the TCR as 
well as three unrelated polypeptides; the human CD4 core- 
ceptor and the 0t and 13 chain of the human MHC class I! 
molecule HLA-DR1  (DR).  The peptide  of the  influenza 
hemagglutinin (HA306-318) was added to the reaction as a 
rigand of DR to promote the formation of peptide-bound 
SDS-stable MHC class II molecules, which migrate as SDS- 
stable heterodimer in SDS-PAGE (44).  This control serves 
to  show  the  ability  of the  in  vitro  system to  support  the 
proper  assembly of this  heterodimer,  in  accord with  our 
earlier studies (40).  After translation, microsomes were sol- 
ubilized in digitonin lysis buffer, subjected to immunopre- 
cipitation  using OKT4  (anti-CD4  mAb),  Tti36  (anti-DR 
mAb), JOVI.1  (anti-TCR-~  mAb),  or OKT3  (anti-CD3 
mAb). The resulting immunoprecipitates were analyzed by 
SDS-PAGE under reducing conditions (Fig.  4 B, left). CD4 
and DR. were recovered only by their appropriate antibod- 
ies.  A  sizable proportion  of DR  displayed the  SDS-stable 
phenotype,  indicative  of proper peptide  loading and  spe- 
cific assembly. The immunoprecipitates obtained with JOVI.1 
(anti-TCR-[3)  and  OKT3  (anti-CD3)  contained  subunits 
of the  TCR  exclusively and were  devoid of co-translated 
CD4 or DR. 
Disulfide  Bonding  of  TCR  Subunits  Translated  In  Vitro. 
To assess the formation of disulfide-hnked subunits,  com- 
plexes recovered withJOVI.1 and OKT3 were analyzed by 
SDS-PAGE under nonreducing  conditions  (Fig.  4  B,  mid- 
dle). We observed the presence of ¢x/13 heterodimers and 
homodimers, as well as the absence of monomeric cx,  [3, 
and  ~  subunits  in  complexes  immunoprecipitated  with 
OKT3. To resolve TCR.-0t from TCR.-I3, immunoprecip- 
itates from JOVI.1  and OKT3 were digested with EndoH 
before separation by reducing SDS-PAGE (Fig.  4 B, right). 
The methionine content (TCR-ot, 4 methionines; TCR-~, 
6  methionines)  and  relative intensity of both  subunits  re- 
covered with OKT3 strongly suggest  a 1:1  stoichiometry for 
both chains, in accordance with in vivo data. 
We  conclude  that the formation of TCR  complexes as 
monitored by coimmunoprecipitation of the relevant sub- 
units occurs in a specific manner. The recovery of TCR-~ 
with  both JOVI.1  and  OKT3  indicate  the  formation  of 
complete TCR complexes, since this subunit joins the TCR 
during  the  last stage  of assembly (10).  Moreover,  specific 
assembly ofmultimolecular complexes (TCR versus DR) can 
occur  simultaneously in  an  in  vitro  translation  system,  as 
complexes containing inappropriate subunits were not ob- 
served. 
CD3-e  Translated Oligomerizes  in  the  Absence  of Related 
CD3 Subunits.  The  CD3-e  chain  contains  two  cysteine 
residues presumably involved in stabilization of the Ig fold, 
and two more cysteines in the lumenal domain (2),  one of 
which is located within a few residues  of the lipid bilayer 
(Fig.  5).  The occurrence of disulfide-linked ~ homodimers 
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Figure 5.  Primary structure of human CD3-~ and its proposed intra- 
chain disulfide bonding  pattern. *Cysteine  residues in the extracellular  do- 
main. The  transmembrane region is  underlined in  the  sequence and 
shaded in the schematic figure. A disulfide bond that stabilizes the Ig fold 
involves cysteine  residues 27 and 76 (57). Two remaining  cysteines  are lo- 
cated close to the membrane  and may be available  for the formation  ofin- 
terchain disulfide bonds 
has been reported in vivo (45,  46), but the monomer is the 
prevalent form found in  riving cells.  We  investigated the 
biochemical properties of CD3-e translated in vitro under 
both reducing and oxidizing conditions. Immunoprecipita- 
tions were performed with the anti-CD3-e antibody in the 
presence of 50  mM iodoacetamide to  prevent the  forma- 
tion  of disulfide  bridges  after lysis.  As visualized by SDS- 
PAGE under nonreducing conditions, translation of CD3-e 
performed  under  oxidizing  conditions  resulted  in  oligo- 
meric structures that collapsed to the monomer when ana- 
lyzed by SDS-PAGE under reducing conditions (Fig.  6 A). 
Moreover, the difference in mobility for the oxidized and 
reduced monomeric form of CD3-~ is clearly visible (Fig.  6 
A,/eft). We noted that it is only the oxidized form of CD3-e 
that coimmunoprecipitated with fully assembled TCR com- 
plexes. We do not know whether the more rapidly migrat- 
ing,  oxidized form of CD3-e contains  any remaining free 
sutfhydryl groups, but we consider this unlikely.  Inclusion 
of DTT in the translation reaction abrogated origomeriza- 
tion but led to a monomeric polypeptide with a slightly de- 
creased mobility, as a  consequence  of alkylation by iodo- 
acetamide upon lysis.  We  confirmed the  homoorigomeric 
nature  of CD3-~  by two-dimensional  gel  electrophoresis 
(first dimension: isoelectric focusing under nonreducing con- 
ditions;  second dimension: reducing SDS-PAGE; data not 
shown). We conclude that CD3-e translated in vitro in the 
absence of related subunits  tends to form mostly disulfide- 
linked origomers, a process that appears to be redox depen- 
dent. 
To investigate whether the quantity of CD3-e expressed 
in  microsomes  exerts  any  influence  on  the  formation  of 
disulfide-linked e oligomers, we translated CD3-~ together 
with increasing amounts of an unrelated  chain,  the DR-J3 
chain.  Total microsome-associated material as well as im- 
munoprecipitates of CD3-e were analyzed by SDS-PAGE 
performed under  both  reducing  and  nonreducing  condi- 
tions (Fig. 6  B). As the ratio between monomeric and disul- 
fide-linked  oligomeric  CD3-~  does  not  depend  on  the 
amount of translated CD3-e (and DR-J3), the formation of homooligomers must be an inherent property of the CD3-• 
subunit. 
We addressed the kinetics of this reaction (Fig. 6  C)  by 
terminating the  translation of CD3-•  after  15  rain by the 
addition  of cycloheximide.  Aliquots  of microsomes  were 
lysed in  the presence  of iodoacetamide at indicated times 
after translation and subjected to immunoprecipitation with 
anti-CD3-e antibodies. Analysis of immune complexes by 
SDS-PAGE performed under  nonreducing  conditions re- 
veals that dimeric CD3-•  was already prevalent at the end 
of the translation period, but higher order forms gradually 
increased with time. 
The  Presence of Related  TCR  Subunits  Prevents the Forma- 
tion of  Disulfide Linked •  Oligomers.  The propensity of CD3-• 
to form disulfide-linked oligomers was examined by translat- 
ing CD3-• either alone or together with the other subunits 
of the TCP,. Total microsome-associated material as well as 
immunoprecipitates obtained from lysed microsomes were 
analyzed by  SDS-PAGE  performed  under  both  reducing 
and nonreducing conditions (Fig. 7 A). Lysis in 0.5% NP- 
40  facilitates the  visualization of CD3-•  as it leads to  the 
disruption of all noncovalent interactions between the sub- 
units of the TCR,  but not those between CD3-•,  -% and 
-8 (6). 
As shown  above,  CD3-•  translated on its own  is found 
primarily in  oligomeric structures.  However,  its behavior 
changes dramatically in the presence of TCI~ subunits, where 
CD3-•  is  now  predominantly  monomeric.  The  role  of 
each individual subunit in "chaperoning" CD3-• was stud- 
ied by translating •  alone and pairwise with other subunits 
of the TCR  or with DR-13. Analysis ofanti-CD3-• immu- 
noprecipitates  by  nonreducing  SDS-PAGE  (Fig.  7  B) 
shows  that in  the presence  of TCR-ot,  -13, -~ and DR-I3 
the formation of e  oligomers is not affected. However, co- 
translation of CD3-~/and CD3-8 drastically shifts the equi- 
librium towards the formation of •  monomers.  The strong 
interaction between CD3-•  and CD3-~/or -8 (which sur- 
vives solubilization in  0.5%  NP-40)  may  account  for this 
effect.  As binding of both  ~/  and  8  to  CD3-•  appears  to 
compete with the formation of •  homooligomers, the high 
degree of homology between CD3-% -8, and, to some de- 
gree,  CD3-•  may be particularly noteworthy  and suggests 
the presence of a  common binding motif for complex for- 
mation.  Since Ig-like domains are present not only in the 
Figure  6.  CD3-e tends to form disulfide linked homo-oligomers. (A) 
CD3-e was translated for 1 h at 30°C in the presence of DTT and GSSG 
at indicated concentrations. Microsomes were lysed in NP-40 lysis  buffer 
in the presence of 50 mM iodoacetamide and immunoprecipitations were 
performed using an antiserum raised against  the cytoplasmic  tail of CD3-~. 
Samples were  analyzed by SDS-PAGE (12.5%) performed under  both 
nonreducing and reducing conditions. The number of covalently linked 
subunits are indicated, red, reduced; ox, oxidized. (B) mRNAs of CD3-e 
and HLA-DR[3 were translated simultaneously at indicated ratios for 1 h 
at 30°C. Microsome-associated  material as well as immunoprecipitates  ob- 
tained in the presence of 50 mM iodoacetamide with the anti-CD3-~ an- 
tiserum were analyzed directly by reducing and nonreducing SDS-PAGE 
(12.5%). (C) Translation of CD3-e was stopped after 15"min by the addi- 
tion of cycloheximide (20 p.M) and aliquots of the translation reaction 
were further incubated at 30°C for the times indicated. Immunoprecipita- 
tions were performed in the presence of 50 n~M iodoacetamide using the 
anti-CD3-~ antiserum. Microsomes were analyzed  directly by SDS-PAGE 
(12.5%) performed under reducing conditions  and inmlunoprecipitates  were 
subjected to SDS-PAGE (12.5%) performed under nonreducing conditions. 
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dependent manner and with oligomeric forms of CD3-e in a glycan-inde- 
pendent manner. CD3-~ and -~ were translated at indicated ratios for 1 h at 
30°C in the absence and presence of the glucosidase  inhibitor 7-O-dec. 
After lysis in NP-40 lysis buffer containing 50 mM iodoacetamide,  im- 
munoprecipitates were obtained with the  indicated  antibodies and ana- 
lyzed  by SDS-PAGE (12.5%)  performed under nonreducing conditions. 
The number of covalenfly  linked e or "y subunits are indicated,  pr., pro- 
cessed N-linked glycans. 
Figure 7.  Co-translation of related TCtL subunits prevents the formation 
of disulfide-linked  ~  homooligomers. (,'t)  CD3-~  was either  translated 
alone or along with the remaining subunits of the TCR-CD3 complex 
for 1 h at 30°C. Microsomes were lysed in NP-40 lysis buffer in the pres- 
ence  of 50  mM iodoacetamide.  Total microsome-associated material  as 
well  as  immunoprecipitates  obtained  with  the  anti-CD3-e  antiserum 
were analyzed  by SDS-PAGE (12.5%)  performed as indicated under re- 
ducing and nonreducing conditions. (B) CD3-e was translated  alone and 
pairwise with one subunit of the TCtL or with HLA-DR~3 as indicated, 
for 1 h at 30°C. Microsomes were lysed in NP-40 lysis buffer in the pres- 
ence of 50 mM iodoacetamide.  Total microsome-associated  material as well 
as immunoprecipitates obtained with the anti-CD3-e antiserum were an- 
alyzed by SDS-PAGE (12.5%) performed under reducing and nonreduc- 
ing conditions as indicated. 
CD3 subunits, but also in the clonotypic c~/[3 heterodimer 
and  in  DR-J3,  the  mere  presence  of Ig-like  domains  is 
clearly not sufficient to confer the ability of blocking ho- 
mooligomerization of CD3-~. 
Complex Formation of Calnexin and Monomeric CD3-6 Can 
Be Mediated by CD3-% but Is Dispensable  for Proper Folding of 
CD3-E.  Calnexin,  a  molecular chaperone, binds  prefer- 
entially to monoglucosylated trimming intermediates in the 
ElK (21). Interestingly it also interacts with free CD3-~ and 
CD3-e  complexed with  CD3-~/  or  -8,  although  CD3-e 
lacks  N-linked  glycans  (24,  47).  How  calnexin  binds  to 
CD3-e is not known.  To study calnexin-CD3-e interac- 
tions  and  their importance for proper folding of CD3-e, 
we designed the following experiment: CD3-~ alone, e and 
y, or y  alone were translated in the absence and presence of 
the  glucosidase  inhibitor  N-7-oxadecyl-dNM  (7-O-dec), 
which  blocks glucose trimming  of N-linked  glycans  (48) 
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and consequently prevents a  glycan-dependent interaction 
between calnexin and glycoproteins. The change in mobility 
for the glycosylated ~ subunit upon translation in the pres- 
ence of 7-O-dec is due to glucose retention and is clearly 
visible on SDS-PAGE. After translation (1-h duration), mi- 
crosomes were lysed in digitonin lysis buffer. Immunopre- 
cipitates  obtained with  antibodies  directed against  calnexin, 
CD3-e,  and -~/were analyzed by SDS-PAGE under non- 
reducing conditions (Fig. 8). 
Translated alone, oligomeric e subunits could be recov- 
ered with  the  anticalnexin antibody regardless  of the  ab- 
sence or presence of 7-O-dec  in  the translation reaction. 
However, the y  subunit strongly interacted with calnexin 
in a glycan-dependent manner, as this interaction appeared 
to be 7-O-dec sensitive.  Monomeric CD3-e was co-immu- 
noprecipitated with  calnexin  in  the  presence  of CD3-% 
Complete sensitivity of this interaction to 7-O-dec implies 
a role of CD3-~  as a bridging intermediate for CD3-',/ in 
this binding. 
Notably, 7-O-dec did not exert any effect on the oligo- 
merization  of CD3-~  translated  alone  or  together  with 
CD3-%  Therefore, for both gtycan-dependent and -inde- 
pendent modes of binding, the interaction of calnexin with 
the CD3-e does itself not influence the oligomerization of 
Figure 9.  Homooligomerization of CD3-~.  The formation of CD3-e 
homooligomers in all  likelihood  involves the  membrane-proximal cys- 
teine residues not involved in stabilization  of the Ig fold. CD3-e. Hence, we conclude that the folding oft is guided 
by the formation of a complex with CD3-~/and most likely 
also  with  CD3-8,  two subunits  competing for binding to 
CD3-e at an early stage of TCR assembly. 
Discussion 
Our understanding of the requirements for the assembly 
of the TCR  stems largely from studies in which the indi- 
vidual subunits were transfected into suitable recipient cell 
lines,  e.g.,  mutant  T  cell lines  deficient in one  of the  six 
subunits  or by transfections  into  nonlymphoid  cells.  The 
expression  of all  subunits  of the  TCR-CD3  complex  is 
necessary and  sufficient to  accomplish its  assembly in  the 
ER and its subsequent expression at the cell surface (49,  50), 
without obvious involvement of lymphoid-specific factors. 
The analysis  of heterooligomerization of the TCR-CD3 
complex in living cells  is  complicated by the  presence of 
widely different pool sizes of the participating subunits, and 
by the egress of incompletely assembled receptors out of the 
ER, a complication avoided in the present study. We sought 
to  reproduce  the  early stages  of the  TCR  assembly in  a 
complete in vitro system, with particular emphasis on the 
role  of the  CD3-e subunit.  We optimized the  translation 
efficiency of all  mRNAs  involved  to  allow  the  simulta- 
neous  translation  of multiple  mRNAs,  without  having to 
consider the confounding effects of the 5' untranslated se- 
quence and signal peptides on the efficiency of translation 
and  membrane  insertion.  In  this  fashion,  we  successfully 
translated  nine  different  mRNAs  simultaneously,  and, 
provided  proper  redox  conditions  were  imposed  on  the 
ER-derived microsomes, observed specific complex forma- 
tion  amongst the  appropriate subunits  produced  in  vitro. 
Specifically, the co-translation of class II HLA-DR-ot and 
-[3  subunits  in  the  presence  of an  appropriate  peptide 
ligand, along with CD4 and all subunits of the TCR-CD3 
complex,  resulted  in  the  formation  of properly  assembled 
TCtk-CD3 complexes, correctly folded CD4 molecules, as 
well  as  peptide-loaded  class  II molecules,  without  cross- 
contamination of any of these complexes by inappropriate 
subunits.  To  our  knowledge,  no  ohgomeric  membrane 
proteins of greater complexity have been generated by in 
vitro translation.  The ability to obtain such complexes tes- 
tifies  to  the  robustness  of these  microsome-supplemented 
in  vitro  systems.  The  actual  concentrations  of the  TCR 
subunits obtained by in vitro translation are difficult to esti- 
mate, but likely to be quite low, compared to the concen- 
trations  of the  proteins  in  the  lumen  of the  microsomes 
used.  The remarkably efficient assembly and folding of the 
polypeptides  analyzed  thus  suggests  the  possibility  that 
these processes might be limited to small numbers of "inser- 
tion sites", where  conditions  for folding and  assembly are 
favorable. Through  association of the translocon with  ac- 
cessory proteins  (N-ohgosaccharyl transferase,  peptidyl disul- 
fide  isomerase,  calnexin),  some  specialization  through  ac- 
complishing this goal within the ER could occur. 
The sequence ofsubunit interactions that leads to a com- 
plete TCR-CD3 complex has been addressed for living cells 
(7,  9).  Given the complexity of this receptor, it is perhaps 
not surprising that assembly occurs in a well ordered  and 
stepwise fashion; the formation of CD3-~//e and 8/e pairs 
takes place early and depends on the specific interaction be- 
tween  their  ectodomains  (15).  Both  CD3-',/  and  CD3-8 
compete for binding to CD3-e (51).  The crucial sites in the 
extracellular  portion of CD3-~/for its interaction with CD3-~ 
are also conserved in the primary structure of CD38, which 
suggests that both CD3-~/and -8 share a common binding 
motif in CD3-e (15).  Next, pairs of CD3-8/e and ~//e re- 
cruit TClk-ot and -J~, respectively. Upon formation of an 
intrachain disulfide bridge between TCR-ot and -[3, trim- 
eric  complexes merge to a  hexameric e~/J3-otSe complex, 
into which  the  ~ homodimer is  integrated  as  the  last re- 
maining subunit. It is noteworthy that the stoichiometry of 
the CD3-TCR  complex is still considered tentative (8). 
When CD3-e is translated  alone, it tends to form disulfide- 
linked homooligomers; moreover, a substantial amount of 
monomeric  CD3-e  is  found  in  a  reduced,  i.e.,  incom- 
pletely, folded state. The quantity of CD3-~ translated and 
inserted into microsomes does not influence the ratio be- 
tween monomeric  (reduced and oxidized)  and oligomeric 
structures. In all likelihood, homooligomerization of CD3-e 
is an inherent property of the e subunit; it is fast and occurs 
under physiological redox conditions.  However, co-trans- 
lation of TCR subunits under conditions that support com- 
plex formation leads to a dramatic change in the balance of 
newly  synthesized  CD3-e  subunits  towards  oxidized  and 
properly folded monomers, the only form of CD3-e recov- 
ered with the conformation-dependent mAb OKT3.  The 
mere co-translation of CD3-',/or -8 was sufficient to keep 
CD3-e primarily in an oxidized and monomeric state, indi- 
cating that  CD3-',/ and -8 guide the folding of CD3-e at 
the initial stage of TCR assembly. 
Although the disulfide bonding status for individual cys- 
teine residues in CD3-e has not been established, we con- 
sider it likely that the Ig fold may facilitate formation of the 
disulfides between the cysteines at position 27 and position 
76, which stabilize this structure.  The extent to which the 
remaining extracellular cysteine residues (at position 97 and 
100)  are  involved  in  disulfide  bonding  in  the  mature 
TCR-CD3  complex is not known.  Our data suggest that 
when no DTT is added,  some CD3-e may not acquire  a 
proper disulfide bonding status.  We therefore cannot indi- 
cate which cysteine residues are involved in the formation 
of these e oligomers. 
The presence of disulfide-linked e homodimers in a com- 
pletely assembled and functional TCR complex has been re- 
ported for several human and murine T  cell lines (45,  46). 
However, the presence of these e  homodimers was estab- 
lished either using conformation-independent anti-CD3-e 
reagents (46)  or by examining immunoprecipitates obtained 
with  the  conformation-specific antibody OKT3  after cell 
surface labeling under oxidative conditions  (45).  Although 
we observe oligomerizaton of CD3-e as a major pathway 
in the  course of its  biosynthesis in the absence of CD3-~/ 
and  -8,  we  could  not  detect  these  structures  as part of a 
complete TCR-CD3 complex by irnrnunoprecipitation with 
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not been mapped accurately, only recovered CD3 subunits 
in immunoprecipitations when these were translated simul- 
taneously with TCR-ot and -[3 under redox conditions that 
allow proper folding (data not shown). Intracellular immu- 
nostaining  of CD3-e  transiently  expressed  in  COS  cells 
could only be achieved with OKT3 when either CD3-~/or 
CD3-8 were coexpressed (52). 
Furthermore,  using OKT3 we could only co-immuno- 
precipitate TCR-{x and -[3 as disulfide-linked heterodimers, 
despite the presence of free TCR~ot, -[3, and CD3 pairs in 
the lysate. Hence, OKT3 most likely recognizes a confor- 
mation-dependent  epitope on CD3-e that becomes avail- 
able when CD3-~/or -8 is present, and remains stable after 
solubihzation  in  detergent  when  the  hexameric  e~/[3--aS~ 
structure  has  been  formed.  A  conformational  change  of 
murine CD3-e, dependent on the presence of routine CD3-y 
or -8,  has  been  reported  (53).  Taken  together,  our  data 
strongly support the notion that CD3-e requires the pres- 
ence of CD3-y or -8 to fold correctly and to allow the as- 
sembly of the TCR-CD3  complex to proceed. 
CD3-to, a nonglycosylated polypeptide of 28 kD, is ex- 
pressed in human T  cells and transiently interacts with pairs 
of CD3-8/~ at an early stage of TCR assembly (54).  Upon 
maturation and egress of the nascent TCR from the ER, it 
is released from the complex (54). CD3-to is commonly re- 
garded as a T  cell--specific  molecular chaperone and hence, 
is likely to be absent from the canine microsomes used in 
this study.  The function  of CD3-to is unknown  since  the 
expression  of CD3-t0  is  dispensable  for the  assembly and 
cell surface expression of the TCR-CD3  complex. 
We  have  also  investigated  the  role  of the  molecular 
chaperone calnexin in the folding of CD3-e. Calnexin binds 
in a prolonged £ashion to misfolded proteins or single sub- 
units that fail to join a complex, suggesting that it may par- 
ticipate in the ER quality control machinery that prevents 
egress of incompletely folded or unassembled polypeptides 
from the  ER  (24,  55).  A  characteristic  of calnexin  is  its 
preference  for  monoglucosylated  trimming  intermediates 
of N-linked glycoproteins (21).  Calnexin can bind exclu- 
sively in a lectin-like fashion, i.e., independent of the fold- 
ing state of the substrate (20),  an observation that ties the 
cycle of deglucosylation and  reglucosylation to  glycopro- 
tein folding (56).  Although the interaction between heavy 
chains of MHC class I molecules and calnexin is only initi- 
ated  by partially  trimmed  glycans,  removal of glycans  of 
class I-calnexin complexes by treatment with EndoH does 
not lead to the dissociation of this complex (21).  Calnexin- 
dependent ER retention has been observed for the nongly- 
cosylated CD3-e subunit transfected into COS cells, based 
on colocalization of CD3-e with mutant forms of calnexin, 
engineered with respect to their retention in the ER  (24). 
The mode of binding between calnexin and CD3-e there- 
fore  appears  to  deviate  from  that  between  calnexin  and 
other molecules. 
When  we translated  CD3-e  in  the  absence  of CD3-~/ 
and -8, we could only detect oligomeric CD3-e subunits in 
a complex with calnexin. Theoretically, this interaction could 
involve  an  unlabeled  ER-resident  protein  that  resides  in 
the  microsomes  used  in  the  translation  experiments  and 
would escape detection. Calnexin can interact in a glycan- 
independent  manner  with  aggregates  of the  glycosylated 
VSV-G protein  (22).  Possibly some structural attribute  of 
such VSV-G protein aggregates might be mimicked by the 
CD3-e oligomer. It will be important to define more accu- 
rately and in molecular terms, how calnexin can engage in 
glycan-independent interactions, and whether the outcome 
of these  interactions  could,  under  certain  circumstances, 
lead to the resolution of the aggregates. 
In conclusion, we have demonstrated that the ohgomer- 
ization  of CD3-e is  a  pathway essentially not used when 
CD3-~/and/or CD3-8 subunits are available. In this sense, 
the  CD3-e could serve as a  subunit  that monitors proper 
oligomerization of the CD3 complex. 
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